FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980693448> ?p ?o ?g. }

• W2980693448 abstract "Abstract Background According to the 2018 NIA-AA research framework, Alzheimer’s disease (AD) is not defined by the clinical consequences of the disease, but by its underlying pathology, measured by biomarkers. Evidence of both amyloid-β (Aβ) and phosphorylated tau protein (p-tau) deposition—assessed interchangeably with amyloid-positron emission tomography (PET) and/or cerebrospinal fluid (CSF) analysis—is needed to diagnose AD in a living person. Our aim was to test the new NIA-AA research framework in a large cohort of cognitively impaired patients to evaluate correspondence between the clinical syndromes and the underlying pathologic process testified by biomarkers. Methods We retrospectively analysed 628 subjects referred to our centre in suspicion of dementia, who underwent CSF analysis, together with neuropsychological assessment and neuroimaging, and were diagnosed with different neurodegenerative dementias according to current criteria, or as cognitively unimpaired. Subjects were classified considering CSF biomarkers, and the prevalence of normal, AD-continuum and non-AD profiles in each clinical syndrome was calculated. The positivity threshold of each CSF biomarker was first assessed by receiver operating characteristic analysis, using Aβ-positive/negative status as determined by amyloid-PET visual reads. The agreement between CSF and amyloid-PET data was also evaluated. Results Among patients with a clinical diagnosis of AD, 94.1% were in the AD-continuum, whereas 5.5% were classified as non-AD and 0.4% were normal. The AD-continuum profile was found also in 26.2% of frontotemporal dementia, 48.6% of Lewy body dementia, 25% of atypical parkinsonism and 44.7% of vascular dementia. Biomarkers’ profile did not differ in amnestic and not amnestic mild cognitive impairment. CSF Aβ levels and amyloid-PET tracer binding negatively correlated, and the concordance between the two Aβ biomarkers was 89%. Conclusions The examination of the 2018 NIA-AA research framework in our clinical setting revealed a good, but incomplete, correspondence between the clinical syndromes and the underlying pathologic process measured by CSF biomarkers. The AD-continuum profile resulted to be a sensitive, but non-specific biomarker with regard to the clinical AD diagnosis. CSF and PET Aβ biomarkers were found to be not perfectly interchangeable to quantify the Aβ burden, possibly because they measure different aspects of AD pathology." @default.
• W2980693448 created "2019-10-25" @default.
• W2980693448 creator A5001461978 @default.
• W2980693448 creator A5014220005 @default.
• W2980693448 creator A5023350680 @default.
• W2980693448 creator A5033308802 @default.
• W2980693448 creator A5036127424 @default.
• W2980693448 creator A5041388512 @default.
• W2980693448 creator A5056427824 @default.
• W2980693448 creator A5064643566 @default.
• W2980693448 creator A5070650545 @default.
• W2980693448 creator A5074420206 @default.
• W2980693448 creator A5076480218 @default.
• W2980693448 creator A5081436063 @default.
• W2980693448 creator A5089549553 @default.
• W2980693448 date "2019-10-15" @default.
• W2980693448 modified "2023-10-18" @default.
• W2980693448 title "Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes" @default.
• W2980693448 cites W1667362502 @default.
• W2980693448 cites W1988370080 @default.
• W2980693448 cites W1992165389 @default.
• W2980693448 cites W2006858320 @default.
• W2980693448 cites W2028436804 @default.
• W2980693448 cites W2042397283 @default.
• W2980693448 cites W2075575934 @default.
• W2980693448 cites W2106931873 @default.
• W2980693448 cites W2111642028 @default.
• W2980693448 cites W2112455323 @default.
• W2980693448 cites W2115017507 @default.
• W2980693448 cites W2116709840 @default.
• W2980693448 cites W2128030851 @default.
• W2980693448 cites W2130983640 @default.
• W2980693448 cites W2131665885 @default.
• W2980693448 cites W2133649359 @default.
• W2980693448 cites W2136557657 @default.
• W2980693448 cites W2138190873 @default.
• W2980693448 cites W2142589181 @default.
• W2980693448 cites W2144707045 @default.
• W2980693448 cites W2149614271 @default.
• W2980693448 cites W2151384687 @default.
• W2980693448 cites W2156220037 @default.
• W2980693448 cites W2160597466 @default.
• W2980693448 cites W2163867016 @default.
• W2980693448 cites W2164443763 @default.
• W2980693448 cites W2168357345 @default.
• W2980693448 cites W2169508236 @default.
• W2980693448 cites W2173601762 @default.
• W2980693448 cites W2213841503 @default.
• W2980693448 cites W2295393683 @default.
• W2980693448 cites W2302528231 @default.
• W2980693448 cites W2473313434 @default.
• W2980693448 cites W2492380270 @default.
• W2980693448 cites W2527609605 @default.
• W2980693448 cites W2592378632 @default.
• W2980693448 cites W2609123133 @default.
• W2980693448 cites W2619097621 @default.
• W2980693448 cites W2623521763 @default.
• W2980693448 cites W2625796101 @default.
• W2980693448 cites W2766248450 @default.
• W2980693448 cites W2780732598 @default.
• W2980693448 cites W2792820766 @default.
• W2980693448 cites W2798054687 @default.
• W2980693448 cites W2801498551 @default.
• W2980693448 cites W2904222299 @default.
• W2980693448 cites W2961942506 @default.
• W2980693448 cites W2971768381 @default.
• W2980693448 cites W4233950638 @default.
• W2980693448 doi "https://doi.org/10.1186/s13195-019-0543-7" @default.
• W2980693448 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6794758" @default.
• W2980693448 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31615545" @default.
• W2980693448 hasPublicationYear "2019" @default.
• W2980693448 type Work @default.
• W2980693448 sameAs 2980693448 @default.
• W2980693448 citedByCount "27" @default.
• W2980693448 countsByYear W29806934482020 @default.
• W2980693448 countsByYear W29806934482021 @default.
• W2980693448 countsByYear W29806934482022 @default.
• W2980693448 countsByYear W29806934482023 @default.
• W2980693448 crossrefType "journal-article" @default.
• W2980693448 hasAuthorship W2980693448A5001461978 @default.
• W2980693448 hasAuthorship W2980693448A5014220005 @default.
• W2980693448 hasAuthorship W2980693448A5023350680 @default.
• W2980693448 hasAuthorship W2980693448A5033308802 @default.
• W2980693448 hasAuthorship W2980693448A5036127424 @default.
• W2980693448 hasAuthorship W2980693448A5041388512 @default.
• W2980693448 hasAuthorship W2980693448A5056427824 @default.
• W2980693448 hasAuthorship W2980693448A5064643566 @default.
• W2980693448 hasAuthorship W2980693448A5070650545 @default.
• W2980693448 hasAuthorship W2980693448A5074420206 @default.
• W2980693448 hasAuthorship W2980693448A5076480218 @default.
• W2980693448 hasAuthorship W2980693448A5081436063 @default.
• W2980693448 hasAuthorship W2980693448A5089549553 @default.
• W2980693448 hasBestOaLocation W29806934481 @default.
• W2980693448 hasConcept C118552586 @default.
• W2980693448 hasConcept C126322002 @default.
• W2980693448 hasConcept C126838900 @default.
• W2980693448 hasConcept C14216870 @default.
• W2980693448 hasConcept C142724271 @default.
• W2980693448 hasConcept C143998085 @default.
• W2980693448 hasConcept C167135981 @default.

• next